Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

57.05
Delayed Data
As of Jun 29
 0.00 / 0.00%
Today’s Change
45.69
Today|||52-Week Range
60.07
+8.01%
Year-to-Date
How J&J Defied Brexit and Became the Year's Top Health Care Stock
Jun 29 / TheStreet.com - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. AbbVie
Jun 27 / MotleyFool.com - Paid Partner Content
How Pfizer, Merck May Feel Long-term Pinch From Brexit
Jun 29 / TheStreet.com - Paid Partner Content
Why Agenus' Stock Has Stumbled in 2016
Jun 27 / MotleyFool.com - Paid Partner Content
The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What?
Jun 28 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Gilead Sciences Bucks Tradition, Takes 'Low Road' on New Hepatitis C Drug Price
Jun 28 / TheStreet.com - Paid Partner Content
Can Gilead Sciences Rebound in the Second Half of 2016?
Jun 25 / MotleyFool.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
Why Investors Are Paying a Premium for These 3 Drugmakers
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close57.05
Today’s openn.a.
Day’s range55.98 - 57.14
Volume477,456
Average volume (3 months)8,953,628
Market cap$154.7B
Dividend yield3.23%
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+4.30%
Revenue growth (last year)-7.92%
P/E ratio34.9
Price/Sales3.87
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc0.000.00%
NVSNovartis0.000.00%
BMYBristol-Myers Squibb0.000.00%
PFEPfizer0.000.00%
Data as of 06/29/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs